The Stanley Medical Research Institute (SMRI) is a nonprofit organization supporting research on the causes of, and treatments for, schizophrenia and bipolar disorder. Since it began in 1989, SMRI has supported more than $550 million in research in over 30 countries around the world.
Treatment trial applications are now being accepted–Deadline is March 1, 2017
Please visit the Treatment Trials page for more information.
This program supports the testing of medications to assess their efficacy for treating schizophrenia and bipolar disorder. At any given time, SMRI is supporting 40-50 treatment trials, the majority of which are generic and/or off-label medications. SMRI expects to fund 5-10 additional trials this year.
Postmortem samples available from cases with schizophrenia, bipolar disorder, major depression & unaffected controls. Mine >2000 neuropathology datasets, microarray, methylation, SNP & RNA-seq datasets from multiple brain areas.